From Target Idea to Synthesizable Molecule

Denovo technologies integrate molecular design, evaluation, and synthetic route generation to shorten discovery timelines and increase candidate success rates.

How we work

Denovo Sciences offers flexible collaboration models to accelerate drug discovery together. Co-Discovery/shared development partnerships enable joint discovery and advancement of promising candidates from hit to preclinical stages.
We also provide end-to-end drug discovery support, from hit and lead finding to lead optimization, leveraging our AI-driven platform to identify and refine high-potential small molecules rapidly.
Finally, our proprietary technologies can be accessed via cloud-based solutions, API integration, or on-premise deployment, giving partners full flexibility to use Denovo’s AI-powered drug discovery tools within their own workflow.

Partnerships

Co-Discovery Share Development

Discovery Services

Hit/Lead Finding Lead Optimization

Software License

Cloud-based API On Premise

Proven track record of discoveries

Our collaborations have resulted in the successful discovery and optimization of multiple small molecules with superior therapeutic and drug-like propertes. Partner with Denovo Sciences to leverage our expertise and state-of-the-art technologies.

  • Flagship Pioneering
  • CIRI
  • Chuv
  • Agency
  • oxford
  • Weill Cornell

Discover how our technologies can accelerate your discovery.

Partner with us to discover new drug candidates.

© 2026, Denovo Sciences

Powered by Munich Ventures